4092 — Nippon Chemical Industrial Co., Ltd.

AI-passives supply-chain cluster: compare vs AP Memory (6531) · AP Memory (6531).

Thesis

Verdict: Low conviction / do-not-chase at ¥5,570; watchlist for a retrace to ¥3,500–4,000 or the early-August Q1 FY3/27 print. Right theme, right asset, wrong price, wrong moment.

Nippon Chemical Industrial makes barium titanate (BaTiO3) dielectric powder — the insulating material inside every multilayer ceramic capacitor (MLCC). It is one of three or four merchant suppliers globally qualified into tier-one MLCC lines, and as of 1 April 2026 it is TDK's named JV partner for next-generation ceramic materials (TDK 51% / NCI 49%). That is a genuinely good asset. The problem is the price.

The stock closed 1 June 2026 at ¥5,570, up 14.4% on the day at a daily limit-up (stop-high), +43% in a week, +95% YTD, sitting exactly at its 52-week high with RSI 71. Market cap ¥48.3B (~$303M), EV ¥48.5B, net debt ~¥6.3B. I went looking for the fundamental event behind the spike and did not find one — no earnings revision, no JV escalation, no capacity announcement, no sell-side initiation dated late May or 1 June. What I found instead: a TrendForce MLCC-rebound call (18 May), the well-worn AI-server MLCC-shortage narrative, a Nomura Asset Management 5.44% large-shareholding disclosure (filed 21 May), and two back-to-back stop-high days that the Japanese financial press (kabutan) explicitly attributes to "speculation about barium titanate for MLCC." Sakai Chemical (4078), the other zero-coverage upstream BaTiO3 micro-cap, ran +44% over the same two weeks. This is a thematic squeeze of the upstream layer, amplified by an 8.68M-share float — not a company-specific re-rating.

Conviction is Low not because the business is bad — it is a fine, cheap-ish, structurally-positioned small-cap — but because the entry is wrong. At ¥3,905 (the 23 May vault profile price, 10.1x forward) this was an interesting value-with-optionality name. At ¥5,570 (14.5x forward, 0.96x book, RSI 71, stop-high) you are paying up for a sentiment move while management's own FY3/27 powder-segment guide decelerates to +4.6% and operating margin sits at 3.9%. Fair-value range ¥3,500–4,500 on disclosed fundamentals; downside target if the theme cools is ¥3,000–3,500 (back toward the ¥3,052 MA200 / book-plus). The right action is to do the work now and wait for the squeeze to exhaust or the Q1 FY3/27 print (early August) to validate demand — not to chase a limit-up.

Snapshot

One-liner: Nippon Chemical is one of three-to-four merchant suppliers qualified to make the sub-100nm barium titanate dielectric powder that gates how thin — and therefore how high-capacitance — a finished MLCC can go; differentiated from Sakai by its oxalate/alkoxide process route and, uniquely, the April-2026 TDK materials JV — but the upstream-MLCC theme has front-run the fundamentals on a stop-high micro-cap with zero sell-side coverage.

• Ticker / exchange: 4092 (4092.T) on the Tokyo Stock Exchange Prime
• Legal name: Nippon Chemical Industrial Co., Ltd. (founded 1893 as Nippon Seiren Co., Ltd.; renamed March 1944); HQ Tokyo; 732 employees; four domestic plants + four overseas sales offices (China, Thailand, Taiwan, USA); nippon-chem.co.jp
• Sector / industry: Basic Materials / Specialty (inorganic) Chemicals — sits at the dielectric-powder ⨯ AI/automotive MLCC intersection, one layer upstream of the MLCC makers
• Spot price: ¥5,310 (2026-06-02; live) — down 4.7% from the ¥5,570 1-June stop-high close; the squeeze is unwinding (intraday 52-wk high ¥6,360 printed before fading). 1 June close ¥5,570 (+95% YTD, +43%/wk, stop-high, RSI 71); 23 May profile price ¥3,905; updated 52-wk range ¥1,955–¥6,360; MA200 ¥3,066.
• Market cap: ¥46.1B (~$290M) at ¥5,310 | EV ¥54.6B (yfinance, gross-debt basis) / ¥48.5B (net-debt basis, page) | net debt ~¥6.3B. (1 June: mcap ¥48.3B; 23 May profile: mcap ¥33.9B, EV ¥40.2B.)
• Valuation (live 2026-06-02 at ¥5,310): trailing P/E 14.0x | forward P/E 13.8x | P/B 0.92x (the lone remaining value marker) | EV/EBITDA 8.95x | EV/Rev 1.36x | FCF yield <1% | dividend yield 2.15% (¥120 trailing) | beta (5Y) 0.96. (At ¥5,570 1 June: P/E 16.8x, EV/EBITDA 7.95x. The Archetype piece anchors "~8x EV/EBITDA"; live is ~9x — slightly fuller than the article assumes.)
• Shares: ~8.68–8.73M (micro-cap, thin float); insiders 16.6% (Tanahashi family overhang); institutional ~23% (passive/quant value — Avantis, DFA, Dimensional); Nomura Asset Management 5.44% (filed 21 May 2026 — first active domestic manager building a stake)
• Coverage: Zero sell-side. No analyst PT, no consensus estimate, no broker model. The "strong_buy" recommendationKey in the data feed is a technical-momentum artifact — ignore it. Information-edge play; management commentary is the entire information set.
• Conviction: Low — do-not-chase at ¥5,570; WATCH ¥3,500–4,000; the August Q1 print is the binary

Business

What it does. Nippon Chemical is a 133-year-old Japanese inorganic specialty-chemicals house — a pure B2B manufacturer, no licensing, no recurring revenue, pricing follows end-market cycles. The whole investment case lives in one sub-line: high-purity barium titanate (BaTiO3) dielectric powder for MLCCs.

Segment naming — flagged discrepancy between the two source files. The 23 May profile organized the company into two reportable segments — Inorganic Chemicals (44% of FY3/26 sales) and Specialty Chemicals (52%) — plus a small Leasing segment. The 1 June deep-dive, after an adversarial fact-check, states the company actually reports four segments — Chemical Products, Functional Products, Leasing, and Air-Conditioning Related — and that it does NOT break out a standalone "barium-titanate" or "electronic-ceramics" revenue line, so any precise powder number is an estimate, not reported data. Both labelings are retained here; the deep-dive's correction is the more recent and was the explicit output of a primary-filing check. The mapping is roughly: legacy book (chromium compounds, silicates/silica, inorganic phosphorus) = profile's "Inorganic Chemicals" / deep-dive's "Chemical Products"; the MLCC-powder-bearing segment (BaTiO3 + battery materials + phosphine/red phosphorus for compound semis + quantum-dot display materials) = profile's "Specialty Chemicals" / deep-dive's "Functional Products."

Segment mix (FY3/26 actuals, ¥M; verified 2026-06-02 against the company's own FY3/26 4Q Results Presentation pp.7–10 — segment-sales and sub-line figures are disclosed; per-sub-line OP is NOT disclosed, only segment-level OP):

Segment / Sub-line	FY3/25 Sales	FY3/26 Sales	YoY	FY3/26 OP	OP Margin	% of total	MLCC / AI exposure
Inorganic Chemicals (= "Chemical Products")	18,285	17,916	−2.0%	1,281	7.1%	44.6%	None — legacy industrial
— Chromium Compounds	5,437	5,456	+0.3%	—	—	13.6%	None (plating)
— Silicates and Silica	2,347	2,327	−0.9%	—	—	5.8%	None
— Inorganic Phosphorus	6,759	6,577	−2.7%	—	—	16.4%	None (general industry)
— Other	3,739	3,554	−4.9%	—	—	8.8%	None
Specialty Chemicals (= "Functional Products")	18,876	21,010	+11.3%	513	2.4%	52.3%	The whole MLCC story lives here
— Electronic Ceramic Materials (BaTiO3 / MLCC powder)	8,446	10,424	+23.4%	[VERIFY — not disclosed]	—	25.9%	Direct. The line.
— Organic Functional Materials	4,212	4,064	−3.5%	—	—	10.1%	Indirect (compound-semi, QD)
— Battery & Electronic Device Materials	4,771	4,714	−1.2%	—	—	11.7%	None — active drag (price war)
— Other	1,446	1,806	+24.9%	—	—	4.5%	Mixed
Leasing + Other	1,681	1,255	−25.3%	592	47.2%	3.1%	None — real-estate annuity
Consolidated	38,843	40,182	+3.4%	2,415	6.0%	100%	—

(Note: the FY3/26 presentation reports Leasing + Other as a combined ¥1,255M with ¥592M OP — the ¥940M/¥559M Leasing-only and ¥315M/¥32M Other split shown in the prior profile breaks the same total apart; the −25.3% YoY is the Book-Store-Operation exit, ¥461M → ¥0, not a Leasing decline. Both retained.)

The single most useful read on the table: Electronic Ceramic Materials — the BaTiO3 / MLCC powder line — is 25.9% of FY3/26 sales (¥10,424M / ¥40,182M), meaningfully larger than Sakai's ~12% MLCC-powder slice, and it is the only line in the company with direct AI-server MLCC exposure. It grew +23.4% YoY in FY3/26. But the Specialty Chemicals segment that houses it saw segment-level OP collapse −57.6% (¥1,213M → ¥513M) — the central tension of the name, decomposed in the Financials section below. The MLCC powder revenue tailwind is real and bigger than at Sakai; the operating-profit translation is materially worse. The rest of the company is either a slow legacy book (chromium, silicates) or an active drag (battery materials, in a price war). A small Leasing segment (3% of sales but ~25% of segment OP, ~47–60% margin) is a high-margin real-estate annuity that quietly props up consolidated profit.

The per-sub-line OP gap is the key data limitation. The company discloses OP at the segment level (Inorganic / Specialty / Leasing) only — it does not publish a standalone operating profit for Electronic Ceramic Materials. So the powder line's true margin is unknowable from filings; the entire bull-vs-bear margin debate (below, and in the Archetype scenario) rests on an estimate of a number the company has chosen not to disclose. Mark every powder-line OP or OP-margin figure [VERIFY] / estimate, not reported.

First principles — why BaTiO3 powder is the moat. An MLCC is a stack of hundreds-to-thousands of alternating layers — a ceramic dielectric and a metal electrode, repeated, co-fired into a monolithic block the size of a grain of rice. Capacitance scales with layer count and inversely with dielectric thickness, so the industry's miniaturization roadmap is a race to make each dielectric layer thinner (now well under 0.5µm for high-cap parts) while keeping it electrically intact. The dielectric is barium titanate — a perovskite ceramic whose ferroelectric lattice stores charge by displacing the central titanium ion, giving the unusually high permittivity that lets MLCCs pack so much capacitance into so little volume. The constraint that creates the moat: to make a 0.3µm layer, your powder particles must be substantially smaller than the layer (sub-100nm to ~200nm), near-perfectly spherical, narrowly distributed, and highly crystalline. Too big and they bridge and short the layer; too irregular and it thins unevenly and breaks down under voltage; poorly crystalline and the dielectric constant collapses. The powder is not a commodity input — it is a precision-engineered material where particle morphology directly gates how thin, and how high-capacitance, the finished MLCC can go.

Two process routes, and where Nippon Chemical differs from Sakai. Sakai (4078) uses hydrothermal synthesis — crystallizing BaTiO3 in high-temperature aqueous solution, the textbook route for the smallest, most spherical, narrowest sub-100nm grades, which is why Sakai claims the high-end merchant leadership. Nippon Chemical uses the oxalate method and the alkoxide method (per management): the oxalate route precipitates a barium-titanyl-oxalate precursor that is calcined to BaTiO3; the alkoxide route is a sol-gel-style hydrolysis of metal alkoxides. Both deliver high-purity, controllable particle size and crystallinity, with morphology that differs from the hydrothermal product — and the 2026 industry has gone hard into rare-earth Dy/Ho-doped core-shell structures (for +30% capacitance in the same package), where some architectures prefer one route's powder over another. The point is not that one route is universally superior — it is that only a handful of firms on Earth can reliably hit the sub-100nm, high-crystallinity, tight-distribution envelope at production scale and pass tier-one MLCC qualification. Qualifying a new powder supplier into a high-cap MLCC line is a 12–24-month process, almost never done unless the incumbent fails. That qualification lock-in — not the chemistry per se — is the durable economic moat.

Value-chain position & the bottleneck. Nippon Chemical sits one layer upstream of the MLCC makers, who sit one layer upstream of the OEMs (Nvidia/hyperscaler AI servers, EV makers, smartphone OEMs). The BoM economics are striking: per Morgan Stanley's NVL72 work (vault MLCC sector note), MLCC content per AI rack rises from ~$1,530 (Blackwell) to ~$4,320 (Rubin), and dielectric powder is a fraction of that — a tiny slice of system cost but a hard supply gate. When hyperscalers will not lose AI-training share over a fraction of a percent of capex, pricing power accrues to whoever holds the bottleneck. But this is a qualification/process bottleneck, not a raw-material one: Nippon Chemical's own inputs (titanium and barium feedstock) are widely available and cheap — low supplier power. That is a weaker form of scarcity than a rare-earth or single-mine input; a well-capitalized entrant (a Chinese state-backed firm) can eventually replicate the process for mid-range grades. The high end holds; the mid-range erodes.

The Tokuyama asset — the single most important development for the thesis. Management completed a "major investment" at the Tokuyama Factory (Shunan City, Yamaguchi) specifically to handle anticipated MLCC barium-titanate demand growth, building a two-site production system paired with Fukushima No.1 (the primary Electronic Ceramic Materials site). The investment-related cost burden is explicitly cited as a main drag on FY3/26 operating profit. The capacity is on; the demand-side ramp has been slower than the FY3/24 medium-term plan baked in. This is the structural setup for FY3/27–FY3/30: operating leverage on a depreciated, paid-for asset base if MLCC demand catches up.

Plant	Location	Status	Notes
Tokuyama Factory	Shunan City, Yamaguchi	Operating	Large-scale BaTiO3 investment completed FY3/26; second Electronic Ceramic Materials site
Fukushima No.1 Factory	Fukushima	Operating	Primary Electronic Ceramic Materials site; now paired with Tokuyama in a 2-site system
Tokyo / other domestic sites	Multiple	Operating	Inorganic chemicals; phosphine derivatives; lithium chloride solution
Aichi Factory	Aichi	Operating	Absorbed Toho Ganryo Kogyo core business (subsidiary dissolved FY3/26)
Overseas sales offices	China, Thailand, Taiwan, USA	Operating	No overseas production disclosed

The TDK JV — the cleanest structural differentiator vs Sakai. TDK-NCI Advanced Materials Co., Ltd. — established 1 April 2026, announced 2 April 2026, located Narita-shi, Chiba.

• Ownership: TDK 51% / Nippon Chemical Industrial 49%.
• Partner: TDK Corporation (6762.T) — top-3 global MLCC maker (~12–13% share), major Apple supplier, ~¥250B annualized MLCC revenue.
• Scope: joint development of "ceramic materials and corresponding manufacturing processes, particularly for MLCCs" plus other electronic-component materials. R&D-focused — no disclosed production volume or pricing commitment.
• Why it matters: this is the mirror image of Murata's MF Material JV (Sept 2023). Where MF Material is Murata internalizing powder supply (negative for both merchant suppliers), the TDK-NCI JV is the opposite — TDK integrating with Nippon Chemical, locking in a top-3 MLCC maker's R&D and material-development pipeline for the next product generations. The single largest structural difference between Nippon Chemical and Sakai today. But be honest about magnitude: TDK is ~12–13% of global MLCC, Murata ~34–40%. The TDK anchor partially offsets the Murata loss; it does not dominate it. Do not model contract revenue from it — model it as a multi-year qualification accelerator with first commercial contribution plausibly FY3/28–29.

Customers & concentration (largely inferred — the company does not disclose concentration).

• TDK (6762) — now the named anchor via the JV; the cleanest structural differentiator vs Sakai, which has no equivalent named customer.
• Tier-one MLCC makers ex-Murata — Samsung Electro-Mechanics, Taiyo Yuden, Yageo, Walsin, Holy Stone, PDC — inferred, unquantified.
• Murata (6981) — declining wallet share as Murata sources more powder through the MF Material JV (Fuji Titanium 70% / Murata 20% / Ishihara Sangyo 10%, since Sept 2023). Murata is only a 20% minority — partial vertical alignment, not full in-housing — but with Murata at ~34–40% of global MLCC, even a partial shift removes addressable merchant market. (Note: the deep-dive's fact-check corrected the MF Material ownership to Fuji Titanium 70% / Murata 20%; the profile had described it more loosely as a "Murata + Ishihara Sangyo + Fuji Titanium JV.")

Sakai's own management has called out "Nippon Chemical Industrial" by name as a Japanese competitor in their dielectric-materials commentary — the two compete head-to-head in the qualified-supplier roster for tier-one MLCC lines. Net customer position is plausibly neutral-to-slightly-positive vs Sakai, because Nippon Chemical has now contracted a named anchor (TDK) where Sakai has only generic "high customer stickiness" language — the cleanest structural argument for Nippon Chemical over Sakai.

Financials

Read the live data tape carefully — it is misleading. The "+22.2% revenue growth" and "+400% earnings growth" on the tape are artifacts: the +22% is the Q4-only YoY comparison (¥9.74B vs ¥7.97B), and the +400% is off a depressed base further inflated by one-off gains. Full-year FY3/26: net sales ¥40.2B (+3.4%), operating profit ¥2.4B (−27.7%), net income ¥2.9B (+13.1%, but ~¥1.3–1.5B was one-off asset and cross-shareholding sale gains). Strip the one-offs and underlying net income is ~¥1.6B — comparable to FY3/24's depressed level. The headline net margin of 7.2% overstates true earnings quality.

Core Four. Growth: consolidated +3.4% FY3/26 full-year, guided +1.5% FY3/27. The story-line is the Electronic Ceramic Materials sub-segment: +23.4% in FY3/26, but guided to decelerate hard to +4.6% in FY3/27 — either management is sandbagging or the +23.4% was channel-fill from Tokuyama coming online plus restocking off the cycle trough. This is the single most important unresolved question in the name. The only multi-year evidence that the trend is durable rather than one-off channel-fill: Electronic Ceramic Materials grew from ¥5.1B (2015) to ¥10.4B (FY3/26) — essentially doubled over a decade — and the combined "growth fields" bucket (Electronic Ceramic Materials + high-purity electronic materials + phosphoric acid for LCDs/semis + phosphorus materials for QD displays) went from ¥8.6B (2018) to ¥15.3B (FY3/25), +78% in 8 years, ~38% of total sales. That long-run line argues the powder ramp is structural; it does not by itself resolve whether the specific +23.4% FY3/26 step was demand or Tokuyama channel-fill. Margins: gross 19.9%, operating 3.87% (thin — the central weakness), EBITDA 15.2%, net 7.2% (one-off-inflated). Specialty Chemicals segment OP collapsed −57.6% as battery-materials price cuts and Tokuyama startup costs swamped the powder lift; FY3/27 guides OP to ¥2.8B (+15.9%) — a recovery, but still below the ¥3.3B mid-term target the company already missed. Capital intensity: high and rising — capex ~¥5.0B FY3/26, guided to ~¥5.9B FY3/27 (+34.5%), OCF ¥5.37B but FCF only ¥361M (FCF margin <1%); the Tokuyama buildout consumes nearly all internal cash, the structural reason capital return is small and the balance sheet carries net debt. Deployment: ¥260M buyback (1.14% of shares), ¥120/share FY3/26 dividend (2.46% yield, 36% payout), cross-shareholding reduction. Conservative. The 2.46% yield is not a firm downside-support marker: the FY3/27 year-end dividend is explicitly "to be determined" — only the ¥60 interim is committed — and management flagged a possible guide-down on shareholder return if H2 underperforms. Treat the yield as contingent, not a floor.

(Note on FCF: the deep-dive states FY3/26 FCF of ¥361M / FCF margin <1%; the profile's cash-flow table shows FY3/26 FCF of ¥1,093M / 2.7% margin and a trailing FCF yield of 3.2%. The gap is a capex-definition difference — the profile uses ¥4,387M capex vs the deep-dive's ~¥5.0B. Both retained; the discrepancy is flagged.)

Income statement & margins (¥M; FY3/24–FY3/26 actuals + FY3/27 mgmt guide):

Metric	FY3/24	FY3/25	FY3/26	FY3/27E (mgmt)
Net sales	38,538	38,843	40,182	40,800
Revenue growth YoY	+1.2%	+0.8%	+3.4%	+1.5%
Gross profit	7,316	8,753	8,000	n/a
Gross margin	19.0%	22.5%	19.9%	n/a
Operating profit	2,264	3,342	2,415	2,800
OP margin	5.9%	8.6%	6.0%	6.9%
Ordinary profit	2,383	3,199	2,375	2,700
Net income	1,590	2,559	2,894	3,000
EPS (¥)	180.35	290.62	331.39	345.75
EBITDA	5,947	6,924	6,155	7,000
Diluted shares (M)	8.82	8.81	8.73	—

FY3/26 net income +13.1% despite OP −27.7% is driven by ~¥1.5B extraordinary income (¥504M gain on sale of non-current assets + ¥1.03B gain on sale of investment securities — cross-shareholding reductions). Underlying earnings quality is weaker than the net-income line suggests.

FY3/27 segment guide (¥M):

Segment	FY3/26 Sales	FY3/27E Sales	Growth	FY3/26 OP	FY3/27E OP	Growth
Inorganic Chemicals	17,916	18,250	+1.9%	1,281	1,600	+24.9%
Specialty Chemicals	21,010	21,300	+1.4%	513	600	+17.0%
— Electronic Ceramic Materials	10,424	10,900	+4.6%	—	—	—
— Battery & Electronic Device	4,714	5,000	+6.1%	—	—	—
Leasing	940	950	+1.1%	559	570	+2.0%
Total	40,182	40,800	+1.5%	2,415	2,800	+15.9%

The crux — why segment OP fell while powder sales rose +23.4%

This is the single most important thing to understand about the FY3/26 print, and it is the load-bearing assumption in every bull scenario on the name. Electronic Ceramic Materials sales rose +23.4% (¥8,446M → ¥10,424M), yet the Specialty Chemicals segment that contains it saw OP fall −57.6% (¥1,213M → ¥513M) and consolidated OP fall −27.7% (¥3,342M → ¥2,415M). The powder growth did not drop to the bottom line. Verified 2026-06-02 from the company's own FY3/26 operating-profit waterfall (4Q presentation p.5), the consolidated ¥3.3B → ¥2.4B bridge decomposes as:

Bridge component	¥B impact	What it is	Recurs?
FY3/25 starting OP	3.3	—	—
Quantity variance	~0	Volume net-neutral (powder up, others flat/down)	—
Price variance	−0.2	Battery-materials price cuts (the ongoing price war)	Yes — structural drag until it clears
Cost variance	−0.3	Absence of the prior-year benefit from reduced inventory-valuation losses (battery materials) — i.e. FY3/25 got a one-time inventory tailwind that did not repeat	No — non-recurring base effect
SG&A / other	−0.4	One-off expenses for the consolidation of production sites (business-efficiency / restructuring; Toho Ganryo Kogyo dissolution → Aichi transfer; Tokuyama two-site startup)	No — one-off
FY3/26 ending OP	2.4	—	—

This maps cleanly onto — and refines — the three drivers the Archetype piece names (battery problems / inventory reversal reversing / restructuring). The refinement matters: the largest single bucket is the SG&A/restructuring one-off (−¥0.4B), not the battery price war (−¥0.2B). Roughly two-thirds of the OP decline (−¥0.7B of the −¥0.9B) is non-recurring — the inventory base-effect and the site-consolidation one-offs do not repeat by construction; only the −¥0.2B battery price drag is structural. That is the bull's strongest factual footing: strip the non-recurring ¥0.7B and underlying OP was closer to ¥3.1B, and the powder revenue did contribute — it was simply masked by drags that mostly clear. The bear's counter is equally factual: the Tokuyama depreciation that the "growth investment" added is now a permanent fixed-cost layer in the run-rate, and the battery price war shows no sign of ending. The August Q1 FY3/27 print is where these two reads get adjudicated — clean sequential OP recovery confirms the one-offs cleared; a flat OP says the Tokuyama fixed cost ate the recovery.

Archetype Capital scenario — "could re-rate 100%, or become far too cheap"

Source / status. Archetype Capital, "Sakai Chemical & Nippon Chemical MLCC Capacity Crunch" (archetype-research.com, 1 June 2026) — one analyst's view, explicitly flagged by the author as incomplete / DYOR, with market sizing sourced to a Zephyr X/Twitter post, 29 May 2026. Attribute, do not treat as fact. The author calls Nippon Chemical the superior, cheaper play vs Sakai, on two grounds: (1) Electronic Materials is ~25% of revenue with likely more AI-server MLCC exposure than Sakai; (2) Nippon uses the oxalate BaTiO3 route — which the author pegs at 21.4% of the market (uniform, high-performance) — vs Sakai's hydrothermal (13.5%) and commodity solid-state (61.8%). Both points are consistent with what this page already holds (powder is 25.9% of sales; oxalate/alkoxide is NCI's named route).

The upside scenario, with assumptions labeled. The author's bull case is a single, clearly-conditional chain:

IF Electronic Ceramic Materials reaches Sakai's ~20% operating margin [assumption 1: a segment OM that is not currently disclosed and is almost certainly far below 20% today] on ~¥12,000M FY2027 revenue [assumption 2: the author's own estimate, +15% over the ¥10,424M FY3/26 base] → ~¥2,400M operating-profit contribution from this one line. That equals the company's entire FY2026 consolidated operating profit (~¥2,415M) — i.e. the powder line alone could roughly double total company OP. On the author's math that compresses the multiple from ~8x EV/EBITDA to ~4x by FY2027 absent any re-rate — "could re-rate 100%, or become far too cheap."

My check on the two assumptions — both are heroic, in opposite directions:

• Assumption 2 (¥12,000M FY27 revenue) is the more defensible. It implies +15% YoY, well above management's own +4.6% guide (¥10,900M) but far below the +23.4% just printed. Given the long-run trend (Electronic Ceramic Materials doubled ¥5.1B → ¥10.4B over a decade; the broader growth-fields bucket +78% in 8 years), a +15% year in a genuine AI-MLCC up-cycle is plausible, and would itself expose management's +4.6% as sandbag. Call it aggressive-but-credible. It is also the entire FY3/27-validation question this page already flags as the binary.

• Assumption 1 (20% segment OM) is where the scenario over-reaches. The author imports Sakai's ~20% Electronic-Materials margin onto Nippon Chemical's powder line. But Nippon Chemical's entire Specialty Chemicals segment ran a 2.4% OP margin in FY3/26 and a normalized ~6% even stripping the one-offs; consolidated OP margin is 3.9–6.0%. For the powder line specifically to earn 20% — a >3x step from anything the company has demonstrated — requires (a) the battery/inventory/restructuring drags to clear (~⅔ of which are genuinely non-recurring, so this part is reasonable), AND (b) the powder line to carry a structurally Sakai-like margin that Nippon Chemical has never disclosed earning and that its 130-year cost structure may simply not support, AND (c) the powder ASP catch-up to the +15–35% finished-MLCC hikes to actually land. The author is effectively assuming Nippon Chemical's undisclosed powder margin already resembles Sakai's disclosed one — possible, since the consolidated number is dragged down by battery/chromium, but unproven and unprovable from filings. A ¥2,400M powder OP is a genuine ceiling-case, not a base case. A more sober "drags clear + ASP catch-up but no margin convergence to Sakai" path lands the powder-line OP contribution somewhere in the ¥800M–1,400M range — a real lift, perhaps +30–50% on company OP, not a double.

Net: the scenario's direction is right and rests on a factually-sound non-recurring-cost observation; its magnitude (a clean double of company OP) chains two estimates the author admits are estimates, the more aggressive of which (20% OM) substitutes a peer's disclosed margin for a number Nippon Chemical refuses to disclose. Treat the ¥2,400M as the bull ceiling, the August print as the first real test of assumption 2, and the powder-line margin as the permanent unknowable that caps how much conviction the scenario can ever carry.

Live valuation vs the article's EV/EBITDA claim (verified 2026-06-02, yfinance). Spot ¥5,310 (down 4.7% from the ¥5,570 1-June stop-high; the squeeze is already unwinding — it printed an intraday 52-wk high of ¥6,360 before fading). Market cap ¥46.1B, EV ¥54.6B (yfinance carries the full ¥14.4B gross debt and nets less cash than the page's ¥48.5B EV — the page figure is the cleaner net-debt EV; both shown), EV/EBITDA 8.95x, trailing P/E 14.0x, forward P/E 13.8x, P/B 0.92x (still ~book — the lone value marker, consistent with the page's ~0.96x), dividend yield 2.15% (¥120 trailing). On the article's "~8x" starting point: the live EV/EBITDA is ~9x on the post-spike price, modestly above the author's 8x anchor — so the re-rate math actually starts from a slightly fuller multiple than the piece assumes. The "→4x by FY2027" leg is entirely a function of the ¥2,400M scenario landing: if the powder line really added ¥2,400M of OP / roughly doubled EBITDA toward ~¥11B (the company's own FY3/30 EBITDA target), then on an unchanged ~¥54B EV the multiple does compress toward ~5x. The arithmetic is internally consistent; it inherits 100% of the heroic ¥2,400M assumption above. The 8x→4x is not a valuation finding — it is the same single scenario restated as a multiple.

Red phosphorus. The author also flags Nippon Chemical's high-purity red phosphorus capacity for optics as undisclosed-magnitude optionality. Confirmed on the page already (red phosphorus / phosphine for compound semis sits in Organic Functional Materials); magnitude genuinely not disclosed, so it is a qualitative call option, not a modelable line. [VERIFY — size unknown].

Cash flow & balance sheet (¥M):

Metric	FY3/23	FY3/24	FY3/25	FY3/26
Operating cash flow	1,494	6,152	6,367	5,370
Capex	3,007	5,255	4,966	4,387
Free cash flow	(1,513)	897	1,070	1,093
FCF margin	(4.0%)	2.3%	2.8%	2.7%
Cash	7,841	8,731	7,628	7,784
Total debt	16,776	16,531	15,075	14,400
Net debt	8,935	7,790	7,148	6,616
Net debt / EBITDA	1.9x	1.3x	1.0x	1.1x
Equity ratio	57.9%	58.9%	61.8%	64.1%
ROE	2.0%	3.6%	5.6%	6.0%

Balance sheet read. Healthy — equity ratio 64.1%, net debt/EBITDA ~1x, D/E target 0.4–0.5 met. But ROE 5.99% sits below an 8–11% cost of equity — the company currently destroys economic value at the margin (ROIC < WACC). That gap is the value-trap risk stated numerically. The bull case is entirely about incremental margins on the depreciated Tokuyama base: if powder volume ramps without proportionate cost, incremental operating margin could be high and ROIC could cross WACC by FY3/29–30 (management's own ¥6.0B OP / 8% ROE FY3/30 target).

Industry landscape

An upstream BaTiO3-dielectric-powder play riding the AI/automotive MLCC content explosion and the 2026 MLCC supply tightening. Industry-wide detail lives on the sector page — see passives-mlcc (the MLCC/passives cluster: Murata, SEMCO, TDK, Taiyo Yuden, and the upstream powder suppliers). Related vault refs: MLCC/mlcc-sector-2026-05-23, MLCC/mlcc-peer-swarm-2026-05-20.

Global MLCC market ~$14–17B, growing 7–9% CAGR to 2030. The dielectric-powder addressable market is small — the deep-dive's independent estimate puts it near ~$0.5B today rising toward ~$1.2B by the mid-2030s (the ~$1.5–2.5B figure the profile cited from other sources looks high — discrepancy retained, deep-dive marked the TAM down). It grows structurally faster than finished MLCCs because the high-cap mix shift raises dielectric-quality requirement per unit. Japanese suppliers (Sakai + Nippon Chemical + MF Material) are often said to hold a large collective share of high-end BaTiO3 (the oft-cited ~40% figure is industry narrative, not audited). Nippon Chemical's individual merchant share is plausibly 10–20% (inference, not disclosed) — below Sakai, whose share independent estimates put at ~25–30% (the company itself has claimed 40–50%; the deep-dive marked it down to ~25–30%).

Server-MLCC sizing (one analyst's view — Zephyr X post, 29 May 2026, cited via Archetype Capital; attribute, do not state as fact). Total MLCC ~$15B; server MLCC ~$1.3B in 2025 ($600M AI-server + $700M general-server). AI-server MLCC growing 80%+ CAGR; general-server 30–40% CAGR (agentic-AI driven); smartphone MLCC negative in 2026–27; humanoids a future leg; book-to-bill >1 at most MLCC suppliers. This is the demand frame underneath the upstream BaTiO3 squeeze — directionally consistent with the TrendForce rebound call and the Murata/Taiyo Yuden price hikes, but it is a single fintwit data point, not audited. The relevant read for 4092: server is still a small slice (~$1.3B of a $15B market) but the fastest-growing one, and powder is the upstream gate on the AI-server portion specifically.

Why now — the sector inflection. This is genuinely the moment the AI-MLCC supply story tightened. In 2026 Murata announced 15–35% price hikes on high-end MLCC (effective April), Taiyo Yuden 6–13%, Yageo 10–20%; Murata's CEO has said customer inquiries run ~2x available capacity. TrendForce (18 May) called an MLCC price rebound driven by high-end demand. Only four firms are qualified for ultra-high-CV AI-grade parts, hyperscalers have locked 60–70% of that capacity, and no near-term supply response is possible. The market has finally connected the dots upstream: if finished MLCCs are constrained and repricing +15–35%, the dielectric powder underneath should reprice too, with a 1–2-quarter lag. That is the real, durable secular tailwind. The 1 June spike is the market front-running it on the wrong instrument at the wrong price — the powder ASP catch-up is a FY3/27-H2 event that has to show up in the financials; the stock has priced a chunk of it in advance via a momentum squeeze.

Management

Long-tenured, internally-promoted leadership. The Tanahashi family name appears across President/Chairman (Hirota Tanahashi), a CHM-level director (Junichi Tanahashi), and a Senior Executive Officer (Hiro Tanahashi) — consistent with multi-generational founder-family governance, though the relationships are not verified from primary disclosure (assumption flag). Insider ownership 16.6% (the family overhang), vs Sakai's 4.27%. Institutional ownership ~23% across ~35 reporting institutions, dominated by passive/quant value funds (Avantis, DFA, Dimensional, WisdomTree); no active concentrated holder, no activist, no sell-side anchor. The one fresh wrinkle: Nomura Asset Management filed a 5.44% large-shareholding report (21 May 2026) — the first sign of a domestic active manager building a position, plausibly part of the catalyst.

Executive roster (directional pending the 25 June 2026 Yuho filing; English bios are thin):

Name	Title	Note
Hirota Tanahashi	President, Chairman, Representative Director	Long-tenured internal promotion; founder-family lineage (unverified)
Junichi Tanahashi	Director (CHM-level)	Likely founder-family
Hiro Tanahashi	Director / Senior Executive Officer	Per LinkedIn — likely related family member
Yuji Kumada	GM, Accounting Department	Investor contact on releases — not separately disclosed as CFO
Nobuyuki Yamazaki	Managing Executive Officer	—
Shoji Konno	Director, Senior Leader	—
Yoshihiro Suzuki	Director	—

Board composition is not broken out in English-language IR materials; full detail is gated on the 25 June 2026 Yuho filing.

Capital allocation — mixed, lean conservative, governance-positive disclosure. Management is candidly self-critical: it acknowledges ROE 6.0% vs cost of equity 8–11%, PBR flagged as "low" (~0.5x at the profile's price), and that it missed its own FY3/26 mid-term OP target of ¥3.3B (actual ¥2.4B, −27%). It has adopted explicit DOE targeting and a 40%-payout-or-2%-DOE dividend floor (a relatively progressive Japanese governance practice), plus a cross-shareholding-reduction program (target ≤10% of net assets). FY3/30 long-term targets restated: ¥6.0B OP / ¥11B EBITDA / 8% ROE. But the capital return is small: the FY3/26 buyback was only ¥260M / 1.14% of shares (79,400 shares for ¥259.8M, complete at cap) vs Sakai's ¥2.5B / 6.17%. FCF of only ~¥0.4–1.1B against ¥5.37B operating cash flow shows where the cash goes — Tokuyama capex. The family-controlled small-cap pattern: disciplined, conservative, slow to return capital, slow to re-rate via activism. Fine for a long-horizon value holder; a headwind for anyone expecting a governance-driven catalyst.

Family-control flag: the 16.6% Tanahashi stake is simultaneously an alignment positive (skin in the game) and a re-rating ceiling (no activist can force balance-sheet optimization). Not a red flag, but a structural reason the multiple stays compressed in normal times — which makes the current above-book multiple all the more clearly sentiment-driven. Key-person risk: Medium — succession is internal-family; a family-controlled small-cap retains its capital-allocation discipline only as long as the family is engaged.

Catalysts & risks

Catalysts (dated).

• 25 Jun 2026 — FY3/26 annual securities report (Yuho) on EDINET: first look at board composition, named-officer comp, any customer-concentration disclosure.
• 26 Jun 2026 — AGM.
• Early Aug 2026 — Q1 FY3/27 results. The decisive print. Does Electronic Ceramic Materials growth stay double-digit (exposing the +4.6% full-year guide as sandbagging, validating the thesis) or collapse to single digits (confirming FY3/26 was channel-fill)? Everything hinges here.
• Continued MLCC sector price-hike headlines and TrendForce/Digitimes data points feeding the theme (and the squeeze).
• Medium-term: FY3/27 H2 powder ASP catch-up to the finished-MLCC price hikes (1–2-quarter lag) — if segment margin expands, thesis confirmed. FY3/28–29 first commercial output from the TDK-NCI JV qualification pipeline (highest-quality call option — TDK is anchored, not merchant-cycle-exposed). FY3/28+ Tokuyama operating leverage as the fixed-cost overhang flips to tailwind, if demand catches up.

Risks (structured).

1. The spike unwinds (highest near-term risk). The +43%/week is a thematic squeeze on an 8.68M-share float, not a fundamental event. RSI 71, stop-high, at the 52-week high. Micro-cap momentum reverses violently; a theme cool-off plus profit-taking sends it back toward MA50 (¥3,491) or MA200 (¥3,052) fast.
2. The +4.6% FY3/27 powder guide is the true run-rate, not sandbagging. If FY3/26's +23.4% was Tokuyama channel-fill and restock, the upstream demand thesis is a slow burn and the stock is badly overpriced.
3. Thin operating margin / value-trap. 3.9% OP margin, ROE below cost of equity, FCF near zero, net debt. A structurally low-return business the market is temporarily pricing as a growth bottleneck.
4. Battery-materials drag inside Specialty Chemicals — ongoing price war, slow to fix, suppresses segment OP recovery.
5. Murata MF Material in-housing erodes wallet share at the largest MLCC maker; the TDK anchor only partially offsets (12–13% vs 34–40% of market).
6. Chinese state-backed mid-range entrants (Hayna, Guoci) structurally erode the bottom of the powder market.
7. Family-control overhang (16.6% Tanahashi) caps activist-driven re-rating and keeps capital return small.

• Longer-term watch item: on-chip integration (embedded deep-trench capacitors, HD-MiM) eating some AI MLCC content — a real 24–36-month watch, not a near-term killer.

Dilution risk: Low. Share count flat at ~8.7M, no ATM, no convert, no warrants; net debt declining. Not a dilution story.

Bear case. Theme cools by August, Q1 FY3/27 shows powder growth reverting to single digits, battery drag persists, OP recovery stalls below the missed ¥3.3B target, and a family-controlled net-debt micro-cap with 3.9% margins and zero coverage de-rates back to ~0.6–0.7x book. Downside target ¥3,000–3,500 (−37% to −46% from ¥5,570).

What invalidates the thesis (the August print is the binary): (a) Q1 FY3/27 powder growth confirms double-digit and management signals an FY3/27 upgrade → bull case validated; or (b) Q1 powder growth single-digit + battery drag persisting → bear case confirmed, exit/avoid.

Valuation / DCF

No formal DCF modeled. Valuation is a multiple-and-book exercise on a zero-coverage micro-cap.

At ¥5,570: trailing P/E 16.8x, forward P/E 14.5x (was 10.1x at the ¥3,905 profile — the spike arbitraged away most of the cheapness), P/B 0.96x (still ~book — the lone remaining value marker), EV/EBITDA 7.95x, EV/Rev 1.21x. Versus Sakai (4078) — cheaper EV/EBITDA ~5.4x, bigger buyback, higher yield — and versus the finished-MLCC names trading 30–50x, Nippon Chemical is mid-pack: no longer cheap, not yet expensive, but priced as if the +4.6% guide is wrong and double-digit powder growth resumes.

Fair-value range ¥3,500–4,500 on disclosed fundamentals. A 0.96x-book micro-cap with a real TDK anchor and a depreciated growth plant is genuinely interesting at ¥3,500–4,000; it is not interesting at ¥5,570 on a stop-high. The asymmetry that existed at ¥3,905 (10.1x forward, near book, TDK optionality) has been largely consumed by the 1 June print.

Pair-trade framing vs Sakai (4078). Where the +22% growth number suggested Nippon Chemical was the cleaner play, the actual picture is roughly even with different risk-reward shapes:

Dimension	Sakai 4078	Nippon Chemical 4092	Edge
MLCC powder revenue % of total	~12%	~26%	NCI
MLCC powder revenue YoY growth	Flat-to-down (FY3/26 guide)	+23.4% actual FY3/26	NCI
Synthesis route	Hydrothermal (claimed share leader)	Oxalate / alkoxide (named competitor)	Sakai
Anchor customer relationship	None disclosed; Murata diversifying away	TDK JV (Apr 2026)	NCI
Production capacity status	Existing; ¥5.7B MLCC capex over 4-yr plan	Tokuyama completed FY3/26 — 2-site	NCI
Forward P/E (at profile prices)	12.8x	10.1x	NCI
EV/EBITDA	5.4x	6.6x (profile) / 7.95x (at ¥5,570)	Sakai
P/B	0.68x	0.67x (profile) / 0.96x (at ¥5,570)	Sakai (now)
Dividend yield	4.62%	3.07% (profile) / 2.46% (at ¥5,570)	Sakai
Buyback authorization	¥2.5B / 6.17%	¥260M / 1.14%	Sakai (4x larger)
ROE	6.6% (FY3/25), 8% target FY3/27	6.0% (FY3/26), 8% target FY3/30	Sakai (tighter)
FY3/26 operating profit growth	+6.7% guided	−27.7% actual	Sakai
Insider ownership	4.27% (no family control)	16.6% (Tanahashi overhang)	Mixed
Sell-side coverage	Zero	Zero	Tied

Neither is a slam-dunk superior. Pick Nippon Chemical for optionality on the TDK JV + Tokuyama operating leverage; pick Sakai for explicit capital return + the named hydrothermal share lead; or own both as a pair and let the upstream BaTiO3 cycle decide which gets re-rated first. But both should be bought on a pullback, not at the stop-high.

The 3-Test. (1) 5-year lock-up — pass on the high end (BaTiO3 is the dielectric in essentially all MLCCs; substitutes are R&D-stage, multi-decade; the only credible long-term displacement is on-chip integration). (2) Unique economic engine — partial (the qualification moat is real, but 3.9% OP margin, 2.4% segment margin, ROE below cost of equity — a unique position that does not yet earn its cost of capital is a weak engine; the bull case is unproven operating leverage on Tokuyama). (3) Blank-check disruptor risk — moderate (state-backed Chinese makers attack mid-range first; high end defended by qualification cycles, but the structural direction is bottom-end share erosion). Cycle: early-to-mid MLCC upswing with finished-MLCC pricing already inflecting and powder ASP catch-up still ahead; the asset is built and depreciating, so incremental demand drops to operating leverage — if demand shows up. That conditional is the entire thesis.

Decision log

2026-06-02 — Financials deepened: segment breakdown verified + Archetype scenario integrated. No change to verdict. Pulled live data (¥5,310, down 4.7% from the 1-June stop-high — squeeze unwinding; EV/EBITDA 8.95x live, P/B 0.92x). Verified the segment split against the company's own FY3/26 4Q presentation (pp.5–10): Electronic Ceramic Materials 25.9% of sales, +23.4%, but per-sub-line OP is NOT disclosed — the powder line's true margin is unknowable from filings, which caps every margin-based bull case. Decomposed the OP-drop crux from the company's own waterfall: the consolidated ¥3.3B → ¥2.4B fall is price −¥0.2B (battery price war, structural), cost −¥0.3B (prior-year inventory-valuation benefit not repeating, non-recurring), SG&A −¥0.4B (site-consolidation one-off, non-recurring) — so ~⅔ of the −¥0.9B is non-recurring, the bull's strongest factual footing, and the largest bucket is restructuring, not battery. Integrated Archetype Capital (1 June 2026, one analyst, DYOR-flagged): its ¥2,400M "powder line could double company OP" scenario chains two estimates — ¥12,000M FY27 revenue (+15%, aggressive-but-credible vs the +4.6% guide) and a 20% segment OM imported from Sakai (heroic — NCI's whole Specialty segment runs 2.4%, ~6% normalized; the powder-line margin is undisclosed). Verdict: direction right, magnitude a ceiling-case not a base-case; a sober "drags clear, no Sakai-margin convergence" path lands ~¥800M–1,400M powder OP, +30–50% on company OP, not a double. The "8x→4x EV/EBITDA" is the same single scenario restated as a multiple, and live EV/EBITDA (~9x) starts fuller than the article's 8x anchor. Added the Zephyr server-MLCC sizing to Industry landscape. Cross-linked passives-mlcc and Sakai (4078).

2026-06-01 — Deep-dive: Low conviction / do-not-chase at ¥5,570; watchlist for a retrace to ¥3,500–4,000 or the August Q1 print. Went looking for the fundamental event behind the +43%/week, two-stop-high spike and found none — it is a thematic squeeze of the upstream BaTiO3 layer (Sakai +44% in the same window), amplified by an 8.68M-share float and the Nomura 5.44% disclosure, attributed by kabutan to "speculation about barium titanate for MLCC." Fair value ¥3,500–4,500; bear target ¥3,000–3,500 (−37% to −46%). The August Q1 FY3/27 print is the binary: double-digit Electronic Ceramic Materials growth validates the thesis (exposes the +4.6% full-year guide as sandbagging), single-digit confirms the +23.4% was channel-fill. Adversarial fact-check this round corrected: segment names (company reports Chemical Products / Functional Products, not Inorganic/Specialty), Sakai share marked to ~25–30%, MF Material ownership to Fuji Titanium 70% / Murata 20%, powder TAM marked down to ~$0.5B→~$1.2B.

2026-05-23 — Profile: factual setup (opinion deferred to deep-dive). Triggered by the Sakai 4078 profile flagging Nippon Chemical as a "cleaner upstream MLCC powder candidate" off a yfinance +22% growth / 10.1x forward P/E. Headline correction: the +22% was a Q4-only YoY figure; full-year FY3/26 was +3.4% with OP DOWN 27.7%; the net-income beat was inflated by ~¥1.5B one-off extraordinary income. Established the structural picture: MLCC powder line is ~26% of revenue (bigger than Sakai's ~12%), grew +23.4% in FY3/26, Tokuyama capacity built and ready for operating leverage, and the TDK JV (Apr 2026) anchors a top-3 MLCC maker — none of which Sakai has. But worse near-term OP trajectory, smaller capital return, weaker FCF, and the Tanahashi family overhang on activist re-rating. Price at writeup ¥3,905 (mcap ¥33.9B). Pair-trade vs Sakai roughly even, different time-horizon shapes.

Position plan. Do-not-chase at spot — watchlist slot, not capital. WATCH ¥3,500–4,000 (near book, TDK optionality, ~10x forward); re-engage on (a) the theme exhausting and a retrace toward MA50 ¥3,491 / book ~¥3,000–3,500, or (b) the early-August Q1 FY3/27 print validating durable powder demand. Sizing: if and when entered, a small, speculative, illiquid starter/optionality position (8.68M-share float, no coverage) — the illiquidity that fuels the upside squeeze fuels the downside gap equally. Not a core holding. Theme construction: vs Sakai (4078), NCI is anchor-optionality (TDK JV + Tokuyama leverage); Sakai is capital-return-plus-share-leadership — both bought on a pullback, not at the stop-high.

Net stance: right theme, right asset, wrong price, wrong moment. The work is done; the name goes on the watchlist for a retrace or an August validation, not the buy list today.

Sources

Fragments folded into this canonical page (consolidated 2026-06-02; originals archived to _migration-archive/2026-06-02/4092/): 4092-t-deep-dive.md (spine, 2026-06-01) · 4092-t-profile.md (2026-05-23).

Appears in / comparisons:

• 6531-vs-4092-showdown — AI-passives supply-chain: silicon-cap COMPONENT (AP Memory 6531) vs MLCC dielectric MATERIAL (Nippon Chemical 4092); both PASS for opposite reasons (composite 3.53 / 2.83)

Related vault pages: passives-mlcc · AP Memory (6531) · Sakai Chemical (4078) · MLCC/mlcc-sector-2026-05-23 · MLCC/mlcc-peer-swarm-2026-05-20 · 6981 Murata · 6976 Taiyo Yuden · 6762 TDK · 2492 Walsin · 6173-two-profile PDC

Key external sources: yfinance live (2 Jun 2026 ¥5,310 / EV/EBITDA 8.95x / P/B 0.92x; 1 Jun 2026; profile 23 May 2026); Nippon Chemical FY3/26 Consolidated Financial Results (13 May 2026, EN) + FY3/26 4Q Results Presentation (22 May 2026) — segment table and OP-drop waterfall re-verified from the presentation text 2 Jun 2026; Archetype Capital, "Sakai Chemical & Nippon Chemical MLCC Capacity Crunch" (archetype-research.com, 1 Jun 2026) — ONE analyst, author-flagged incomplete/DYOR; source of the ¥2,400M powder-OP scenario, the oxalate-route 21.4%-of-market framing, and the red-phosphorus optionality; Zephyr X post, 29 May 2026 (server-MLCC sizing: $15B total, $1.3B server, AI 80%+ CAGR — cited second-hand via Archetype) + "Initiatives for a Sustainable Increase in Corporate Value" FY2025 update (13 May 2026) + Medium-Term Business Plan FY2024–2026 (Nov 2023); TDK press release — TDK-NCI Advanced Materials JV (2 Apr 2026) + basic-agreement announcement (27 Nov 2025); All-About-Industries (JV detail); TipRanks (buyback execution; FY3/26 profit/dividend); Simply Wall St (¥1.3B one-off gain identification, 5-yr −5.4% earnings CAGR); Indian Chemical News / Chemical Research Insight (Top-10 MLCC dielectric-materials ranking 2025); kabutan (1 Jun stop-high attribution); TrendForce (18 May MLCC rebound call); Nomura Asset Management large-shareholding report (5.44%, 21 May 2026); Morgan Stanley NVL72 MLCC-content work (via vault MLCC sector note). SemiAnalysis cross-check: no SA coverage of Nippon Chemical, barium titanate, MLCC dielectric powders, or the TDK-NCI JV in the local mirror (SA's MLCC coverage is one stale Feb-2022 bearish Murata roundup) — coverage gap, not contradiction.

Filings: /filings 4092.T is not yet wired for TDnet/EDINET; the next discrete data point is the 25 June 2026 Yuho (full board composition, named-officer comp, customer-concentration disclosure if any). No 4092-filings.md exists yet.